Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany
Florian Schwarz, Habibollah Arefian, Michael Hartmann, Ingo Runnebaum
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEconomic and Financial Impacts of Cancer · Health Systems, Economic Evaluations, Quality of Life · Neutropenia and Cancer Infections
There is an error in affiliation 5 for author Ingo Runnebaum. The correct affiliation 5 is: Cancer Center Central Germany, Jena, Germany.
The reference list from the paper itself. Each links out to its DOI / PubMed record.